Loading...
Uploaded by MedPageToday on Oct 31, 2008
http://www.medpagetoday.com/John S. Sundy, M.D., Ph.D., Duke in Durham, N.C.SAN FRANCISCO, Oct. 27 -- Severe refractory gout may respond to intravenous infusion of the investigational agent pegloticase (Puricase), researchers found.
Education
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)